UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 97

Sortiert nach

311: A CXCR4-positive subpopulation exhibits cancer stem cell properties in renal cell carcinoma

European journal of cancer (1990), 2014-07, Vol.50, p.S74-S74

2014

Link zum Volltext

Verfügbarkeit prüfen

Lysis of Prostate Carcinoma Cells by Trifunctional Bispecific Antibodies ({{alpha}}EpCAM {{alpha}}CD3)

The journal of histochemistry and cytochemistry, 2001-07, Vol.49 (7), p.911-917

2001

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic gene-modified tumor cells (RCC-26 IL-7 CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study

Gene therapy, 2011-04, Vol.18 (4), p.354-363

2011

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic retrovirally transduced, IL-2- and IFN-γ-secreting cancer cell vaccine in patients with hormone refractory prostate cancer-a phase I clinical trial

The journal of gene medicine, 2007-07, Vol.9 (7), p.547-560

2007

Link zum Volltext

Verfügbarkeit prüfen

Cytotoxic Markers and Frequency Predict Functional Capacity of Natural Killer Cells Infiltrating Renal Cell Carcinoma

Clinical cancer research, 2006-02, Vol.12 (3), p.718-725

2006

Link zum Volltext

Verfügbarkeit prüfen

Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse

Gene therapy, 2000-12, Vol.7 (23), p.2007-2014

2000

Link zum Volltext

Verfügbarkeit prüfen

Renal cell carcinoma‐infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes

International journal of cancer, 2003-10, Vol.106 (6), p.905-912

2003

Link zum Volltext

Verfügbarkeit prüfen

Adoptive tumor therapy with T lymphocytes enriched through an IFN-γ capture assay

Nature medicine, 2001-10, Vol.7 (10), p.1159-1162

2001

Link zum Volltext

Verfügbarkeit prüfen

Isolation of Circulating Cancer Cells From Whole Blood By Immunomagnetic Cell Enrichment and Unenriched Immunocytochemistry In Vitro

The Journal of urology, 2003-02, Vol.169 (2), p.701-705

2003

Link zum Volltext

Verfügbarkeit prüfen

Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium

Cancer Immunology, Immunotherapy, 2009-10, Vol.58 (10), p.1701-1713

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 trial of allogeneic gene-modified tumor cell vaccine RCC-26/CD80/IL-2 in patients with metastatic renal cell carcinoma

Human gene therapy, 2010-03, Vol.21 (3), p.285

2010

Link zum Volltext

Verfügbarkeit prüfen

RNA Transfer by Electroporation into Mature Dendritic Cells Leading to Reactivation of Effector-Memory Cytotoxic T Lymphocytes: A Quantitative Analysis

Molecular therapy, 2005-10, Vol.12 (4), p.734-743

2005

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic vaccination for renal cell carcinoma: development and monitoring

Bone marrow transplantation (Basingstoke), 2000-05, Vol.25 Suppl 2 (S2), p.S83-S87

2000

Link zum Volltext

Verfügbarkeit prüfen

HSP expression in human leukocytes is modulated by endurance exercise

Medicine and science in sports and exercise, 2000-03, Vol.32 (3), p.592-600

2000

Link zum Volltext

Verfügbarkeit prüfen

Influence of CD80, Interleukin-2, and Interleukin-7 Expression in Human Renal Cell Carcinoma on the Expansion, Function, and Survival of Tumor-Specific CTLs

Clinical cancer research, 2005-03, Vol.11 (5), p.1733-1742

2005

Link zum Volltext

Verfügbarkeit prüfen

Cancer gene therapy with a retrovirally transduced IL2-IFNγ-secreting allogeneic tumorvaccine in patients with progressive hormone refractory prostate cancer—A phase I/II trial

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.5127-5127

2007

Link zum Volltext

Verfügbarkeit prüfen

Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells

World journal of urology, 2005-07, Vol.23 (3), p.166-174

2005

Link zum Volltext

Verfügbarkeit prüfen

HLA-A0201-positive, IL-7/B7.1-cotransfected allogeneic tumor cells as a vaccine in metastatic renal cell cancer—A clinical phase-I trial

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.3072-3072

2007

Link zum Volltext

Verfügbarkeit prüfen

Vaccination against B-cell chronic lymphocytic leukemia with trioma cells: Preclinical evaluation

Clinical cancer research, 2003-09, Vol.9 (11), p.4240-4246

2003

Link zum Volltext

Verfügbarkeit prüfen

49 THERAPEUTIC VACCINATION IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE CANCER - RESULTS OF AN OPEN-LABELED PHASE I/II TRIAL WITH AN IL2-IFN-Y SECRETING ALLOGENEIC TUMORVACCINE

European urology supplements : official journal of the European Association of Urology, 2009-03, Vol.8 (4), p.133-133

2009

Link zum Volltext

Verfügbarkeit prüfen

A phase I/II trial of an allogeneic IL2-IFNγ-secreting tumor vaccine in patients with hormone refractory prostate cancer (HRPC)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.4748-4748

2005

Link zum Volltext

Verfügbarkeit prüfen

Long-term culture of monoclonal human T lymphocytes: models for immunosenescence?

Mechanisms of ageing and development, 1995-09, Vol.83 (3), p.171-183

1995

Link zum Volltext

Verfügbarkeit prüfen

Extrathymic Development and Function of Human T-Lymphocytes from Bone Marrow Cells in Vitro

Cellular immunology, 1994-03, Vol.154 (1), p.25-42

1994

Link zum Volltext

Verfügbarkeit prüfen

Role of three quantitatively dominant endogenous peptides from HLA-DRB10401 molecules in class II specific alloreactivity

Transplant immunology, 1994-12, Vol.2 (4), p.293-299

1994

Link zum Volltext

Verfügbarkeit prüfen

Gill surface area of water-breathing freshwater fish

Reviews in fish biology and fisheries, 1992-09, Vol.2 (3), p.187-216

1992

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(83)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(60)
Science & Technology
(57)
Life Sciences & Biomedicine
(55)
Biological And Medical Sciences
(31)
Male
(21)
Medical Sciences
(20)
Dermatology
(15)
Adult
(14)
Fundamental And Applied Biological Sciences. Psychology
(14)
Immunology
(14)
Female
(13)
Middle Aged
(12)
T-Lymphocytes - Immunology
(12)
Molecular Sequence Data
(11)
Aged
(9)
Cell Biology
(9)
Oncology
(9)
Base Sequence
(8)
Biotechnology & Applied Microbiology
(8)
Bullous Diseases Of The Skin
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

311: A CXCR4-positive subpopulation exhibits cancer stem cell properties in renal cell carcinoma

Lysis of Prostate Carcinoma Cells by Trifunctional Bispecific Antibodies ({{alpha}}EpCAM {{alpha}}CD3)

Allogeneic gene-modified tumor cells (RCC-26 IL-7 CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study

Allogeneic retrovirally transduced, IL-2- and IFN-γ-secreting cancer cell vaccine in patients with hormone refractory prostate cancer-a phase I clinical trial

Cytotoxic Markers and Frequency Predict Functional Capacity of Natural Killer Cells Infiltrating Renal Cell Carcinoma

Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse

Renal cell carcinoma‐infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes

Adoptive tumor therapy with T lymphocytes enriched through an IFN-γ capture assay

Isolation of Circulating Cancer Cells From Whole Blood By Immunomagnetic Cell Enrichment and Unenriched Immunocytochemistry In Vitro

Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium

Phase 1 trial of allogeneic gene-modified tumor cell vaccine RCC-26/CD80/IL-2 in patients with metastatic renal cell carcinoma

RNA Transfer by Electroporation into Mature Dendritic Cells Leading to Reactivation of Effector-Memory Cytotoxic T Lymphocytes: A Quantitative Analysis

Allogeneic vaccination for renal cell carcinoma: development and monitoring

HSP expression in human leukocytes is modulated by endurance exercise

Influence of CD80, Interleukin-2, and Interleukin-7 Expression in Human Renal Cell Carcinoma on the Expansion, Function, and Survival of Tumor-Specific CTLs

Cancer gene therapy with a retrovirally transduced IL2-IFNγ-secreting allogeneic tumorvaccine in patients with progressive hormone refractory prostate cancer—A phase I/II trial

Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells

HLA-A0201-positive, IL-7/B7.1-cotransfected allogeneic tumor cells as a vaccine in metastatic renal cell cancer—A clinical phase-I trial

Vaccination against B-cell chronic lymphocytic leukemia with trioma cells: Preclinical evaluation

49 THERAPEUTIC VACCINATION IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE CANCER - RESULTS OF AN OPEN-LABELED PHASE I/II TRIAL WITH AN IL2-IFN-Y SECRETING ALLOGENEIC TUMORVACCINE

A phase I/II trial of an allogeneic IL2-IFNγ-secreting tumor vaccine in patients with hormone refractory prostate cancer (HRPC)

Long-term culture of monoclonal human T lymphocytes: models for immunosenescence?

Extrathymic Development and Function of Human T-Lymphocytes from Bone Marrow Cells in Vitro

Role of three quantitatively dominant endogenous peptides from HLA-DRB10401 molecules in class II specific alloreactivity

Gill surface area of water-breathing freshwater fish

Suchergebnisse filtern